Allowing Greater Access to Safe and Effective Contraception Act

• •The Secretary of Health and Human Services must prioritize review of supplemental applications for oral contraceptives intended for routine use.
• •Priority review is excluded for emergency contraceptives or drugs approved for induced abortion.
• •Drugs approved under this process would be available over-the-counter for individuals aged 18 and older.
• •The FDA must waive application fees for drugs receiving this priority review.
• •Contraceptive drugs remain subject to prescription requirements for individuals under age 18.
• •The Comptroller General must conduct a study on federal funding for contraception over the 15 years preceding the bill's enactment.
• •The GAO report must cover funding from Medicare, Medicaid, Indian Health Service, Health Benefit Exchanges, Federally-qualified health centers, Title X, TANF, and TRICARE.
• •The GAO report is due to Congress within one year of the bill's enactment.

The bill would change the regulatory approval process for certain oral contraceptives to become available over-the-counter for adults 18 and older, while requiring a comprehensive audit of federal contraceptive funding across multiple government programs.

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.